PTX 2.27% 4.5¢ prescient therapeutics limited

Ann: PTX-200 Phase 1B/2 Clinical Trial Update, page-8

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 1,753 Posts.
    lightbulb Created with Sketch. 634
    The result today was excellent.It will be interesting to see the market action over the next few weeks.,will the market wake up that the announcement that further undervalues the stock or will the market remain risk adverse and let it quietly go by, judging the announcement harshly in the current circumstances.

    On the other hand this announcement may attract interest from US investors bearing in mind that,it is cheap in US dollar terms, M&A activity is at record levels in the health care sector in the US, and it is basically a US company with directors having connections in the US and Paul Hooper in based in Los Angeles, but lets see what happens.
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.